GLA POV Archives - Global Lyme Alliance GLA POV Archives - Global Lyme Alliance

COVID 19: Am I Immune?

Does a positive antibody test mean a person is immune and safe from spreading the virus? by Robert Kobre, Chairman, Global Lyme Alliance The Global Lyme Alliance (“GLA”) has acquired an expertise in antibodies and …MORE

Do we need clinical trials, even for long-used ...

With the need for fast treatment options, for COVID-19 and other diseases, is it necessary to re-approve drugs already approved by the FDA? by Timothy J. Sellati, Ph.D., Chief Scientific Officer, Global Lyme Alliance There …MORE

Lyme Arthritis: The Antibody Connection

by Mayla Hsu, Ph.D., Director of Research and Science, GLA Lyme disease, caused by Borrelia burgdorferi bacteria, often leads to arthritis, with up to 60 percent of late-stage patients suffering from painful joints and swelling. …MORE

Is the Clinical Trials Process Working?

GLA’s Chief Scientific Officer takes an important look at our current clinical trials process. Is it still working? Does it serve patient needs?   by Timothy J. Sellati, Ph.D., Chief Scientific Officer, Global Lyme Alliance …MORE

The Advantage of Public-Private Partnerships to...

GLA’s CEO Scott Santarella shares his insight on how scientific advancements that benefit patients can be accelerated through public-private partnerships, as he witnessed during his previous work in cancer research, and see now with both …MORE

COVID-19: Is a Vaccine the Answer?

Point of View: Looking through the Lyme disease lens in weighing the vaccine and treatment path for COVID-19   by Robert Kobre, Chairman, Global Lyme Alliance The United States is currently in a struggle between …MORE

Research Sharing: What Can Lyme Disease Learn f...

Is it possible to leverage research findings and treatment options for malignant cancers, like skin cancer, for Lyme disease?   by Timothy J. Sellati, Ph.D., Chief Scientific Officer, Global Lyme Alliance At the outset, the …MORE

Pandemics, Ecology, and Food Production: Is The...

Why and how do pandemics emerge? Is there a connection between our ecosystems and global food production?   by Mayla Hsu, Ph.D., Director of Research and Science, GLA Why do infectious disease pandemics emerge? In …MORE

Why Are Virus Infections Like COVID-19 Resistan...

While many bacteria can be treated with antibiotics, it’s not the same for virus infections like COVID-19   by Mayla Hsu, Ph.D., Director of Research and Science, GLA Why can’t we treat COVID-19 with antibiotics? …MORE

What Can We Learn from Our Response to COVID-19?

What can we learn from Lyme disease patients and our work in tick-borne disease research that can be applied to the current COVID-19 crisis?   by Robert Kobre, Chairman of the Board, Global Lyme Alliance …MORE

GLA Response to Proposed IDSA/AAN/ACR 2019 Draf...

The Infectious Diseases Society of America (IDSA), along with the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR), recently published a public request for comments on the “2019 Draft Guidelines for …MORE

How the New “Maybe It’s Lyme”...

Is this becoming a trend? Another opinion piece on Lyme disease that dismisses post-treatment and chronic Lyme disease. The author calls these debilitating stages of Lyme an “identity” for people rather than an illness. And …MORE

GLA POV: Ability of Stationary Phase Persister/...

by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA Ying Zhang, Ph.D., a Global Lyme Alliance (GLA)-funded investigator, and his team at Johns Hopkins University just published a seminal study in the journal Discovery Medicine titled …MORE

Request for Information: Input on NIH Tick-born...

Below is a letter from Global Lyme Alliance’s Chief Scientific Officer in response to the NIH’s request for information to their Tick-borne Diseases Strategic Plan   As Chief Scientific Officer of GLA, I herewith respond …MORE

Top 7 Science-Based Events to Impact Lyme Disea...

GLA’s Chief Scientific Officer and Director of Research and Science identified the Top 7 science-based events to impact the Lyme disease community in 2018   Connection Between Lyme Disease and Depression GLA-funded investigator, Brian Fallon …MORE

GLA POV: Essential Oils as Treatment Against Ly...

by Mayla Hsu, Ph.D., Director of Research and Science, GLA Global Lyme Alliance’s Director of Research and Science offers perspective on newly published research on using essential oils to treat Lyme disease   Global Lyme …MORE

GLA POV: Antimicrobial Action of Calprotectin T...

by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA GLOBAL LYME ALLIANCE’S CHIEF SCIENTIFIC OFFICER OFFERS PERSPECTIVE ON NEWLY PUBLISHED GLA-FUNDED RESEARCH OUT OF JOHNS HOPKINS BLOOMBERG SCHOOL OF HEALTH   A Global Lyme Alliance (GLA)-funded …MORE

GLA POV: Identifying Vancomycin as an effective...

by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA Global Lyme Alliance’s Chief Scientific Officer offers perspective on newly published GLA-funded research out of Northeastern University   Although the underlying premise of a recent study by …MORE

REMEMBERING ONE OF OUR OWN

by Scott Santarella, CEO of Global Lyme Alliance Kasey Passen was driven to help others in the fight against Lyme disease Some people have dreams about changing people’s lives but, through no fault of their …MORE

GLA Point of View on New Tick-Borne Co-infectio...

by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA Lyme disease is the most commonly occurring vector-borne disease in the United States. The number of cases reported to the Centers for Disease Control and Prevention (CDC) …MORE

GLA POV: FDA Clears Quidel Lyme Disease Immunoa...

by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA Global Lyme Alliance’s Chief Scientific Officer offers perspective on the new FDA approved Lyme disease blood test. The U.S. Food and Drug Administration recently cleared the Quidel company’s …MORE

GLA Point of View on “First Multiplex Tes...

by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA Advances in Serodiagnostic Testing for Lyme Disease Are at Hand …the TBD-Serochip represents an important advance and significant improvement over existing tests for tick-borne diseases (TBDs), which …MORE

GLA Point of View on New Lyme Disease Study

by Timothy Sellati, Ph.D., Chief Scientific Officer, GLA A study funded in part by Global Lyme Alliance could spur further investigation into the cause of persistent symptoms, a source of medical controversy. A controversial aspect of …MORE

GLA POV: Advances in Serodiagnostic Testing for...

by Timothy J. Sellati, Ph.D. Chief Scientific Officer Global Lyme Alliance GLA Point of View on “Advances in Serodiagnostic Testing for Lyme Disease Are at Hand” published in Clinical Infectious Diseases   In 2016, a scientific …MORE

The Lyme Disease Divide

How to Make Sense of Conflicting Lyme Disease Facts   by Scott Santarella, CEO, Global Lyme Alliance With the possible exception of HIV, no infectious disease in recent history has been as misunderstood and divisive …MORE

Lyme Disease Prevention Needs Co-Operation, Not...

by Hannah Staab and Mayla Hsu, Ph.D., GLA Science Officer With the election of a new President in the United States, the heated rhetoric about reinforcing America’s southern border has ignored the critical need for …MORE

Letter from CEO on Lyme Disease Research Initia...

Global Lyme Alliance CEO Scott Santarella highlights key research initiatives in the 2015-2016 grants cycle.   Thanks to the generosity of our donors, Global Lyme Alliance has had an exceptionally productive year. We have awarded …MORE

Preload
Translate »